BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• FDA

  Mylan Inc. Receives FDA Approval for Generic Version of Parkinson’s Treatment Parcopa(R) ODT Represents Another Mylan First-to-Market Opportunity

  September 22, 2008

   · 

  1 min read
• Policy

  FDA Meeting Provides Green Light for Cell Therapeutics, Inc. Submission of Supplemental Filing for Zevalin(R) Label Expansion Supplemental Biologics License Application (sBLA) on track for Q4 Submission

  September 22, 2008

   · 

  6 min read
• Lone Star Bio

  CSMG Technologies Updates Shareholders on Key Developments, Including Recent U.S. FDA and European CE Mark Clearance for Live Tissue Connect Surgical Device, Targets Initial Sales

  September 22, 2008

   · 

  1 min read
• Drug Development

  RegeneRx Biopharmaceuticals, Inc. Enrolls First Subject in RGN-352 Phase IB Clinical Trial

  September 22, 2008

   · 

  1 min read
• Drug Development

  MAP Pharmaceuticals, Inc. Announces Completion of Enrollment in Phase 3 Trial of Unit Dose Budesonide in Children with Asthma

  September 22, 2008

   · 

  3 min read
• Business

  Ceragenix Pharmaceuticals, Inc. Satisfies Conditions for $1 Million Milestone Payment under Supply and Distribution Agreement

  September 22, 2008

   · 

  1 min read
• Drug Development

  Transdel Pharmaceuticals, Inc. Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial

  September 22, 2008

   · 

  5 min read
• Smith & Nephew plc - Transaction in Own Shares

  September 22, 2008

   · 

  1 min read
• Drug Development

  Baxter International, Inc. Initiates Phase III Trial for the Treatment of Alzheimer’s Disease

  September 22, 2008

   · 

  6 min read
• Genetown

  Boston Scientific Corporation to Participate in UBS Global Life Sciences Conference

  September 22, 2008

   · 

  1 min read